Topic
Biotech
245 published works
The Right Coast
US Blacklists Dozens of Chinese Biotech Firms That Aid Military, Including for Brain-Control Weaponry
The United States on Dec. 16 placed trade and investment restrictions on dozens of Chinese entities over their role in weaponizing biotechnology and other U.S. innovations to bolster the Chinese…
The Right Coast
Can an Athlete s Blood Enhance Brainpower? – The New York Times
What if something in the blood of an athlete could boost the brainpower of someone who doesn t or can t exercise? Could a protein that gets amplified when people…
China Law Insight
科创板生物医药企业上市案例的实证分析研究
By King & Wood
导言 科创板作为我国境内资本市场改革的“试验田”，主要服务于符合国家战略、突破关键核心技术、市场认可度高的科技创新企业。生物医药行业被誉为“永远的朝阳行业”，在科创板中亦占据着重要的地位。截至2021年11月1日，科创板已受理申请的652家公司（其中12家终止后二次申报的公司不重复计算）中，生物医药企业就占据了其中的132席，占比20.25%。 近年来，我国医药市场保持着超过全球医药市场的增速增长。根据Frost & Sullivan的统计，2016年-2020年我国医药行业市场规模从13294亿元增长至17919亿元。中商产业研究院预测，2021年我国医药市场将会继续保持增长趋势，2021年我国医药行业市场规模将达18858亿元。从细分市场规模上来看，根据中商产业研究院预测，2021年我国化学药品、中药、生物制剂市场规模将分别达到1255亿美元、753亿美元、635亿美元。
The Patent Playbook
A Reminder of Doctrine of Equivalents in Biotechnology: Jennewein Biotechnologie GmbH v. International Trade Commission
By Tamaria Dewdney, Fangli Chen
Doctrine of equivalents (DOE) can be applied as a mechanism to hold a party liable for patent infringement even if the product or process does not literally infringe a patent…
Cleary Foreign Investment and International Trade Watch
New Biotech Export Controls Expand CFIUS Mandatory Notification Requirements
By Chase D. Kaniecki, Pete Young
Earlier this week, the U.S. Department of Commerce, Bureau of Industry and Security (“BIS”) published a final rule (the “Final Rule”) imposing export controls on additional emerging technologies pursuant to…
Health Law Prof Blog
CRISPR, Like any Other Technology: Shedding Determinism & Reviving Athens
Jon Khan (York University), CRISPR, Like any Other Technology: Shedding Determinism & Reviving Athens, 19 Can. J. L. & Tech. 173 (2021):This article examines current narratives surrounding CRISPR (clustered regularly…
The D&O Diary
SEC Files COVID-19-Related Enforcement Suit Against Biotech Firm
As the pandemic has progressed and as time has passed, one question I am regularly asked is whether we will continue to see COVID-19 related legal actions being filed. If…
RF EMerge
Amgen Acquires Multispecific Immunotherapy Biotech Startup TeneoBio
On July 27, 2021, Amgen announced that it will acquire Bay area-based Teneobio, a privately held, clinical stage biotechnology company developing multispecific and bispecific molecules including biologics called Human Heavy-Chain…
Healthcare Law Insights
Alumni John Sholar Named General Counsel of jCyte, Inc.
jCyte, Inc., a biotech company dedicated to improving the lives of patients with retinal degenerative diseases, today announced the further expansion of the company’s executive management team with the appointment…
The Healthcare Investor
Healthcare & Life Sciences Private Equity Deal Tracker: Sixth Street Leads $830 Million Investment Into Caris Life Sciences
Sixth Street has led an $830 million growth equity investment into Caris Life Sciences, according to a news release. Caris, based in Irving, Texas, develops molecular profiling assays for oncology…